Trial intelligence / Profile preview

Ropivacaine for Post Thoracotomy Pain in Oncologic Surgery

NCT00210132Phase 2Completed

Sponsor
Institut Bergonié
Start
Oct 2003
Primary completion
Jun 2006
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 2, randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by Institut Bergonié. Primary endpoint: Proportion of Patients With Major Post-operative Pain at Mobilization at 48 hours. Started Oct 2003; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00210132.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00210132.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call